<DOC>
	<DOCNO>NCT01705704</DOCNO>
	<brief_summary>This retrospective study evaluate association biomarkers treatment response patient chronic hepatitis B , complete therapy Pegasys ( peginterferon alfa-2a ) ± lamivudine . For analysis store serum sample obtain patient use ; actual patient involve .</brief_summary>
	<brief_title>A Retrospective Biomarker Study Stored Samples Obtained From Patients With Chronic Hepatitis B</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Hepatitis B , Chronic</mesh_term>
	<criteria>Patients HBeantigen positive negative chronic hepatitis B , chronic viral infection complete therapy Hepatitis B Pegasys ± lamivudine Inclusion criterion relevant clinical study WV16240 , WV16241 , Neptune/WV19432 Samples patient treat either Pegasys Pegays + lamivudine include analytical study Samples analyze patient Investigational Review Board approval grant Exclusion criterion relevant clinical study WV16240 , WV16241 , Neptune/WV19432</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>